您的位置: 首页 > 农业专利 > 详情页

MÉTHODE IN VITRO POUR LE PRONOSTIC OU LA PRÉDICTION DE LA RÉPONSE DE PATIENTS SOUFFRANT DE POLYARTHRITE RHUMATOÏDE AU TRAITEMENT AVEC DES AGENTS RECONNAISSANT LE RÉCEPTEUR MEMBRANAIRE CD 20 DES LYMPHOCYTES B
专利权人:
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIVERSITARI VALL D'HEBRON
发明人:
申请号:
EP10791644.7
公开号:
EP2447374B1
申请日:
2010.06.09
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
In vitro method for the prognosis or prediction of response in patients with rheumatoid arthritis to treatment with agents recognising the B-lymphocyte CD20 membrane receptor. The method of the invention comprises an assay in a blood sample from these patients and measuring, before starting the treatment, the transcriptional expression level (mRNA) of at least one of the genes selected from the group: ARG1, CPD, TRAF1, C1QA, LRRN3, HLA-DQA1, NLK, TLR4, LOC89944, TOM1L1, BACH, NCALD, EIF2C2, NFIC, PCDHB7, FLJ32770, ARID3A, C140RF9, CSNK1E, BCAS1, TEAD2, C6orf145 and SNTA1; and the comparison of this expression level to the expression values previously obtained in patients who responded and who did not respond to the treatment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充